Illumina, Inc. (NASDAQ:ILMN) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Illumina, Inc.

In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Genetic Disorders, Expanding Clinical Applications, and Technologica ...

The Global Bioinformatics Market is expected to grow at a rate of 13-14% by 2029. The rising government initiatives and ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry’s decline of 1.3%. The stock has also outperformed the sector in the ...

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance ...

Here we recount highlights from constituents of the ROBO Global Robotics and Automation Index (ROBO) and the ROBO Global ...